 | • レポートコード：MRC2302C067 • 出版社/出版日：360iResearch / 2023年2月3日 • レポート形態：英語、PDF、236ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：食品 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社では、2021年に252.4億ドルであった世界の医療食市場規模が、2022年に266.6億ドルに達し、2027年には年平均成長率5.79%で353.9億ドルまで成長すると予測しています。当調査レポートでは、医療食の世界市場の現状について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、競争状況などの構成でまとめております。セグメント分析では、カテゴリー別（代謝障害計算式、栄養学的完全なフォーミュラ、栄養学的不完全なフォーミュラ、経口補水製品）、流通チャネル別（オンライン販売、小売販売）、用途別（ADHD、アルツハイマー型認知症、化学療法による下痢、慢性腎臓病、その他）、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）の情報が含まれています。なお、当市場の主要企業には、Arkema S.A.、BASF SE、Bharat Petroleum Corporation、Chevron Corporation、Clariant AG、Dalian Richfortune chemicals Co. Ltd、Dow Inc.、DuPont Tate & Lyle Bio Products Company, LLC、Eastman Chemical Company、Exxon Mobil Corporation、Global Heat Transfer Ltd.、Huntsman Corporation、Indian Oil Corporation Limited、LANXESS Corporationなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の医療食市場規模：カテゴリー別 - 代謝障害計算式の市場規模 - 栄養学的完全なフォーミュラの市場規模 - 栄養学的不完全なフォーミュラの市場規模 - 経口補水製品の市場規模 ・世界の医療食市場規模：流通チャネル別 - オンライン販売の市場規模 - 小売販売の市場規模 ・世界の医療食市場規模：用途別 - ADHDにおける市場規模 - アルツハイマー型認知症における市場規模 - 下痢における市場規模 - 慢性腎臓病における市場規模 - その他用途における市場規模 ・世界の医療食市場規模：地域別 - 南北アメリカの医療食市場規模 アメリカの医療食市場規模 カナダの医療食市場規模 ブラジルの医療食市場規模 … - アジア太平洋の医療食市場規模 日本の医療食市場規模 中国の医療食市場規模 インドの医療食市場規模 韓国の医療食市場規模 台湾の医療食市場規模 … - ヨーロッパ/中東/アフリカの医療食市場規模 イギリスの医療食市場規模 ドイツの医療食市場規模 フランスの医療食市場規模 ロシアの医療食市場規模 … - その他地域の医療食市場規模 ・競争状況 ・企業情報 |
The Global Medical Food Market size was estimated at USD 25.24 billion in 2021 and expected to reach USD 26.66 billion in 2022, and is projected to grow at a CAGR 5.79% to reach USD 35.39 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Medical Food to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Category, the market was studied across Formulas for Metabolic Disorders, Nutritionally Complete Formulas, Nutritionally Incomplete Formulas, and Oral Rehydration Products.
Based on Distribution Channel, the market was studied across Institutional Sales, Online Sales, and Retail Sales.
Based on Application, the market was studied across ADHD, Alzheimer’s Disease, Chemotherapy Induced Diarrhoea, Chronic Kidney Diseases, Depression, Diabetic Neuropathy, Irritable Bowel Syndrome, Minimal Hepatic Encephalopathy, Nutritional Deficiency, Orphan Diseases, Pathogen Related Infections, and Ulcerative Colitis.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Medical Food market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Medical Food Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Medical Food Market, including Abbott Laboratories, Accera, Inc., Ajinomoto Cambrooke, Inc., Alfasigma S.p.A., Danone S.A., Entrinsic Health Solutions, Inc., Fresenius Kabi, Guardion Health Sciences, Inc., Mead Johnson, Meiji Holdings Company, Ltd., Metagenics, Inc., Nestlé S.A., Primus Pharmaceuticals, Primus Pharmaceuticals, inc., Targeted Medical Pharma, and VayaPharma..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Medical Food Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Medical Food Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Medical Food Market?
4. What is the competitive strategic window for opportunities in the Global Medical Food Market?
5. What are the technology trends and regulatory frameworks in the Global Medical Food Market?
6. What is the market share of the leading vendors in the Global Medical Food Market?
7. What modes and strategic moves are considered suitable for entering the Global Medical Food Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of geriatric disorders, Alzheimer disease or type 2 diabetes
5.1.1.2. Need for disease or deficiency specific nutrition and dietary management
5.1.1.3. Increasing popularity of medical foods among healthcare providers in North America & Europe
5.1.2. Restraints
5.1.2.1. Unclarity and lack of reimbursement
5.1.3. Opportunities
5.1.3.1. Medical food for combating retinal disease
5.1.3.2. Nutrient and microbiological analyses of medical foods
5.1.3.3. Improved product accessibility with development of online distribution channels
5.1.4. Challenges
5.1.4.1. Misleading labelling as medical foods
5.2. Cumulative Impact of COVID-19
6. Medical Food Market, by Category
6.1. Introduction
6.2. Formulas for Metabolic Disorders
6.3. Nutritionally Complete Formulas
6.4. Nutritionally Incomplete Formulas
6.5. Oral Rehydration Products
7. Medical Food Market, by Distribution Channel
7.1. Introduction
7.2. Institutional Sales
7.3. Online Sales
7.4. Retail Sales
8. Medical Food Market, by Application
8.1. Introduction
8.2. ADHD
8.3. Alzheimer’s Disease
8.4. Chemotherapy Induced Diarrhoea
8.5. Chronic Kidney Diseases
8.6. Depression
8.7. Diabetic Neuropathy
8.8. Irritable Bowel Syndrome
8.9. Minimal Hepatic Encephalopathy
8.10. Nutritional Deficiency
8.11. Orphan Diseases
8.12. Pathogen Related Infections
8.13. Ulcerative Colitis
9. Americas Medical Food Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Medical Food Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Medical Food Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Accera, Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Ajinomoto Cambrooke, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Alfasigma S.p.A.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Danone S.A.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Entrinsic Health Solutions, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Fresenius Kabi
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Guardion Health Sciences, Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Mead Johnson
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Meiji Holdings Company, Ltd.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Metagenics, Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Nestlé S.A.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Primus Pharmaceuticals
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Primus Pharmaceuticals, inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Targeted Medical Pharma
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. VayaPharma.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing